European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Cardiovascular drug tenders in Portugal — market report, April 2025

Cardiovascular drug tenders in Portugal in April 2025: 194 tenders published (-21% month on month, +29% year on year), estimated at €11,456,424 in total, and 175 contracts awarded (-15% month on month, +52% year on year), worth €865,132 (awarded value). Buyers with the most tenders: Unidade Local de Saúde de Santo António, E. P. E. (24), Unidade Local de Saúde do Alto Minho, EPE (ULSAM) (18) and Unidade Local de Saúde de Santa Maria, E. P. E. (16); most contracts won: Generis – Farmaceutica, S.A. (24), MYLAN, Lda. (17) and Fresenius Kabi Pharma Portugal (13). On average 15.7 bids per contract; 6% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
194
Contracts awarded
175
Contract value awarded
€865,132
Bids per contract
15.7
Tenders published per month
0100200300400Apr 24: 150Apr 24: 150Apr 24May 24: 70May 24: 70May 24Jun 24: 83Jun 24: 83Jun 24Jul 24: 50Jul 24: 50Jul 24Aug 24: 11Aug 24: 11Aug 24Sep 24: 142Sep 24: 142Sep 24Oct 24: 183Oct 24: 183Oct 24Nov 24: 15Nov 24: 15Nov 24Dec 24: 220Dec 24: 220Dec 24Jan 25: 312Jan 25: 312Jan 25Feb 25: 246Feb 25: 246Feb 25Mar 25: 247Mar 25: 247Mar 25Apr 25: 194Apr 25: 194194Apr 25
Contracts awarded per month
0100200300400Apr 24: 115Apr 24: 115Apr 24May 24: 53May 24: 53May 24Jun 24: 80Jun 24: 80Jun 24Jul 24: 44Jul 24: 44Jul 24Aug 24: 10Aug 24: 10Aug 24Sep 24: 144Sep 24: 144Sep 24Oct 24: 173Oct 24: 173Oct 24Nov 24: 30Nov 24: 30Nov 24Dec 24: 311Dec 24: 311Dec 24Jan 25: 231Jan 25: 231Jan 25Feb 25: 320Feb 25: 320Feb 25Mar 25: 206Mar 25: 206Mar 25Apr 25: 175Apr 25: 175175Apr 25

The highlighted bar is April 2025. Hover a bar for its figure; the table below has every value.

FigureApril 2025March 2025ChangeApril 2024Change
Tenders published194247-21%150+29%
Estimated value€11,456,424——€41,490+27,512%
Buyers1923-17%190%
Contracts awarded175206-15%115+52%
Contract value (awarded)€865,132€13,022,339-93%——
Winners2947-38%24+21%
Bids per contract15.711.9—16.7—
Single-bid contracts6%4%—1%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Grande Lisboa 1

Procedures

  • not stated 193
  • Restricted procedure 1

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Cardiovascular and anticoagulant drugs

Questions and answers

How many cardiovascular drug tenders were published in Portugal in April 2025?
194 (by 19 buyers); for comparison, March 2025: 247, April 2024: 150.
Who won the most cardiovascular drug tenders in Portugal in April 2025?
By number of contracts: Generis – Farmaceutica, S.A. (24), MYLAN, Lda. (17), Fresenius Kabi Pharma Portugal (13), Hikma Farmacêutica (Portugal) Sa. (12) and Baxter Medico – Farmaceutica (9); 29 companies won contracts in all.
Which buyers published the most cardiovascular drug tenders in April 2025?
Unidade Local de Saúde de Santo António, E. P. E. (24), Unidade Local de Saúde do Alto Minho, EPE (ULSAM) (18), Unidade Local de Saúde de Santa Maria, E. P. E. (16), Unidade Local de Saúde do Alto Alentejo, E. P. E. (15) and Unidade Local de Saúde de Lisboa Ocidental, E. P. E. (13).
How competitive were cardiovascular drug tenders in Portugal in April 2025?
On average 15.7 bids per contract (108 contracts with a known number of bids); 6% of contracts had a single bid.
What were the contracts worth in April 2025?
€865,132 (awarded value, 175 contracts); median about €12,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.